ID

38710

Beschrijving

Albiglutide Glucose Clamp Study in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01475734

Link

https://clinicaltrials.gov/show/NCT01475734

Trefwoorden

  1. 30-10-19 30-10-19 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

30 oktober 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Diabetes Mellitus, Type 2 NCT01475734

Eligibility Diabetes Mellitus, Type 2 NCT01475734

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
historical diagnosis of type 2 diabetes mellitus for at least 6 months and less than 10 years before screening
Beschrijving

Non-Insulin-Dependent Diabetes Mellitus Disease length

Datatype

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C0872146
hba1c <10% at screening for subjects who do not require washout of existing oad or <9% at screening for subjects who do require washout from existing oad
Beschrijving

Hemoglobin A1c measurement | Absence Washout Antidiabetics Oral | Washout Antidiabetics Oral

Datatype

boolean

Alias
UMLS CUI [1]
C0474680
UMLS CUI [2,1]
C0332197
UMLS CUI [2,2]
C1710661
UMLS CUI [2,3]
C0935929
UMLS CUI [2,4]
C1527415
UMLS CUI [3,1]
C1710661
UMLS CUI [3,2]
C0935929
UMLS CUI [3,3]
C1527415
body mass index in range 28 kg/m2 to40 kg/m2
Beschrijving

Body mass index

Datatype

boolean

Alias
UMLS CUI [1]
C1305855
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of pancreatitis or current ongoing symptomatic biliary disease or pancreatitis
Beschrijving

History of pancreatitis | Gall Bladder Disease Symptomatic | Pancreatitis Symptomatic

Datatype

boolean

Alias
UMLS CUI [1]
C3887021
UMLS CUI [2,1]
C0016977
UMLS CUI [2,2]
C0231220
UMLS CUI [3,1]
C0030305
UMLS CUI [3,2]
C0231220
history of significant gastrointestinal surgery,
Beschrijving

Gastrointestinal Surgical Procedure

Datatype

boolean

Alias
UMLS CUI [1]
C0524722
history of significant cardiovascular disease
Beschrijving

Cardiovascular Disease

Datatype

boolean

Alias
UMLS CUI [1]
C0007222
history of a seizure disorder
Beschrijving

Epilepsy

Datatype

boolean

Alias
UMLS CUI [1]
C0014544
documented hypertension or hypotension
Beschrijving

Hypertensive disease | Hypotension

Datatype

boolean

Alias
UMLS CUI [1]
C0020538
UMLS CUI [2]
C0020649
use of oral antidiabetic agents, except for metformin, within 14 days before investigational product administration.
Beschrijving

Antidiabetics Oral | Exception Metformin

Datatype

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1527415
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0025598
current hepatic disease or abnormal liver function tests
Beschrijving

Liver disease | Liver function tests abnormal finding

Datatype

boolean

Alias
UMLS CUI [1]
C0023895
UMLS CUI [2]
C0151766
positive test result for hepatitis b, hepatitis c, or human immunodeficiency virus infection 1 or 2
Beschrijving

Hepatitis B test positive | Hepatitis C test positive | HIV-1 test positive | HIV-2 test positive

Datatype

boolean

Alias
UMLS CUI [1]
C1608966
UMLS CUI [2]
C1609517
UMLS CUI [3]
C1328593
UMLS CUI [4]
C1168371
history of regular alcohol consumption (exceeding 7 drinks/week for women or 14 drinks/week for men)
Beschrijving

Alcohol consumption Regular | Alcoholic drinks per week | Gender

Datatype

boolean

Alias
UMLS CUI [1,1]
C0001948
UMLS CUI [1,2]
C0205272
UMLS CUI [2,1]
C0001967
UMLS CUI [2,2]
C0332174
UMLS CUI [3]
C0079399
female subject is pregnant (confirmed by laboratory testing), lactating, or less than 6 weeks postpartum
Beschrijving

Pregnancy | Breast Feeding | Postpartum Period

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0086839
known allergy to any glp-1 analog or excipients of albiglutide, baker's yeast, or insulin
Beschrijving

Hypersensitivity GLP-1 Analogue | Hypersensitivity Albiglutide Excipient | Hypersensitivity Saccharomyces cerevisiae | Insulin allergy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C3273809
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C2607479
UMLS CUI [2,3]
C0015237
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0036025
UMLS CUI [4]
C0571622
history of type 1 diabetes,
Beschrijving

Diabetes Mellitus, Insulin-Dependent

Datatype

boolean

Alias
UMLS CUI [1]
C0011854
prior exposure to glp-1 agents, including albiglutide
Beschrijving

Exposure to GLP-1 Receptor Agonist | Exposure to Albiglutide

Datatype

boolean

Alias
UMLS CUI [1,1]
C0332157
UMLS CUI [1,2]
C2917359
UMLS CUI [2,1]
C0332157
UMLS CUI [2,2]
C2607479
blood donation over 500 ml within 8 weeks before screening
Beschrijving

Blood Donation Amount Timespan

Datatype

boolean

Alias
UMLS CUI [1,1]
C0005794
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0872291

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT01475734

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Non-Insulin-Dependent Diabetes Mellitus Disease length
Item
historical diagnosis of type 2 diabetes mellitus for at least 6 months and less than 10 years before screening
boolean
C0011860 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Hemoglobin A1c measurement | Absence Washout Antidiabetics Oral | Washout Antidiabetics Oral
Item
hba1c <10% at screening for subjects who do not require washout of existing oad or <9% at screening for subjects who do require washout from existing oad
boolean
C0474680 (UMLS CUI [1])
C0332197 (UMLS CUI [2,1])
C1710661 (UMLS CUI [2,2])
C0935929 (UMLS CUI [2,3])
C1527415 (UMLS CUI [2,4])
C1710661 (UMLS CUI [3,1])
C0935929 (UMLS CUI [3,2])
C1527415 (UMLS CUI [3,3])
Body mass index
Item
body mass index in range 28 kg/m2 to40 kg/m2
boolean
C1305855 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
History of pancreatitis | Gall Bladder Disease Symptomatic | Pancreatitis Symptomatic
Item
history of pancreatitis or current ongoing symptomatic biliary disease or pancreatitis
boolean
C3887021 (UMLS CUI [1])
C0016977 (UMLS CUI [2,1])
C0231220 (UMLS CUI [2,2])
C0030305 (UMLS CUI [3,1])
C0231220 (UMLS CUI [3,2])
Gastrointestinal Surgical Procedure
Item
history of significant gastrointestinal surgery,
boolean
C0524722 (UMLS CUI [1])
Cardiovascular Disease
Item
history of significant cardiovascular disease
boolean
C0007222 (UMLS CUI [1])
Epilepsy
Item
history of a seizure disorder
boolean
C0014544 (UMLS CUI [1])
Hypertensive disease | Hypotension
Item
documented hypertension or hypotension
boolean
C0020538 (UMLS CUI [1])
C0020649 (UMLS CUI [2])
Antidiabetics Oral | Exception Metformin
Item
use of oral antidiabetic agents, except for metformin, within 14 days before investigational product administration.
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0025598 (UMLS CUI [2,2])
Liver disease | Liver function tests abnormal finding
Item
current hepatic disease or abnormal liver function tests
boolean
C0023895 (UMLS CUI [1])
C0151766 (UMLS CUI [2])
Hepatitis B test positive | Hepatitis C test positive | HIV-1 test positive | HIV-2 test positive
Item
positive test result for hepatitis b, hepatitis c, or human immunodeficiency virus infection 1 or 2
boolean
C1608966 (UMLS CUI [1])
C1609517 (UMLS CUI [2])
C1328593 (UMLS CUI [3])
C1168371 (UMLS CUI [4])
Alcohol consumption Regular | Alcoholic drinks per week | Gender
Item
history of regular alcohol consumption (exceeding 7 drinks/week for women or 14 drinks/week for men)
boolean
C0001948 (UMLS CUI [1,1])
C0205272 (UMLS CUI [1,2])
C0001967 (UMLS CUI [2,1])
C0332174 (UMLS CUI [2,2])
C0079399 (UMLS CUI [3])
Pregnancy | Breast Feeding | Postpartum Period
Item
female subject is pregnant (confirmed by laboratory testing), lactating, or less than 6 weeks postpartum
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0086839 (UMLS CUI [3])
Hypersensitivity GLP-1 Analogue | Hypersensitivity Albiglutide Excipient | Hypersensitivity Saccharomyces cerevisiae | Insulin allergy
Item
known allergy to any glp-1 analog or excipients of albiglutide, baker's yeast, or insulin
boolean
C0020517 (UMLS CUI [1,1])
C3273809 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C2607479 (UMLS CUI [2,2])
C0015237 (UMLS CUI [2,3])
C0020517 (UMLS CUI [3,1])
C0036025 (UMLS CUI [3,2])
C0571622 (UMLS CUI [4])
Diabetes Mellitus, Insulin-Dependent
Item
history of type 1 diabetes,
boolean
C0011854 (UMLS CUI [1])
Exposure to GLP-1 Receptor Agonist | Exposure to Albiglutide
Item
prior exposure to glp-1 agents, including albiglutide
boolean
C0332157 (UMLS CUI [1,1])
C2917359 (UMLS CUI [1,2])
C0332157 (UMLS CUI [2,1])
C2607479 (UMLS CUI [2,2])
Blood Donation Amount Timespan
Item
blood donation over 500 ml within 8 weeks before screening
boolean
C0005794 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0872291 (UMLS CUI [1,3])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial